These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8185209

  • 1. On the influence of CCK receptor blockade on GRP-mediated pancreatic secretion.
    Stöckmann F, Nustede R, Schlemminger R, Köhler H, Ramadori G, Peiper HJ.
    Ann N Y Acad Sci; 1994 Mar 23; 713():427-8. PubMed ID: 8185209
    [No Abstract] [Full Text] [Related]

  • 2. Effect of L-364,718 on GRP-stimulated pancreatic and gastric secretions and GI peptides in conscious dogs.
    Hosotani R, Chowdhury P, Huang YS, McKay D, Yajima H, Rayford PL.
    Pancreas; 1989 Mar 23; 4(5):550-5. PubMed ID: 2813326
    [Abstract] [Full Text] [Related]

  • 3. Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats.
    Konturek SJ, Bilski J, Hladij M, Krzyzek E, Cai RZ, Schally AV.
    Digestion; 1991 Mar 23; 49(2):97-105. PubMed ID: 1724767
    [Abstract] [Full Text] [Related]

  • 4. Effects of cholecystokinin and gastrin antagonists on pancreatic exocrine secretion stimulated by gastrin-releasing peptide.
    Terashima H, Debas HT, Bunnett NW.
    Pancreas; 1992 Mar 23; 7(2):212-9. PubMed ID: 1553370
    [Abstract] [Full Text] [Related]

  • 5. Antagonism of receptors for gastrin, cholecystokinin and GRP/bombesin in postprandial stimulation of exocrine pancreas in dogs.
    Konturek SJ, Tasler J, Bilski J, Cieszkowski M, Cai RZ, Schally AV.
    J Physiol Pharmacol; 1993 Mar 23; 44(1):43-53. PubMed ID: 8390873
    [Abstract] [Full Text] [Related]

  • 6. Gastrin-releasing peptide and cholecystokinin in the regulation of exocrine pancreatic secretion in dogs.
    Nustede R, Schmidt WE, Lohmann C, Köhler H, Schlemminger R, Schafmayer A.
    Digestion; 1993 Mar 23; 54(2):79-83. PubMed ID: 8319843
    [Abstract] [Full Text] [Related]

  • 7. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A, Warzecha Z, Konturek SJ, Banas M, Cai RZ, Schally AV.
    J Physiol Pharmacol; 1991 Sep 23; 42(3):263-77. PubMed ID: 1665365
    [Abstract] [Full Text] [Related]

  • 8. L-364,718, a new CCK antagonist, inhibits postprandial pancreatic secretion and PP release in dogs.
    Hosotani R, Chowdhury P, Rayford PL.
    Dig Dis Sci; 1989 Mar 23; 34(3):462-7. PubMed ID: 2646088
    [Abstract] [Full Text] [Related]

  • 9. Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally.
    Moriyoshi Y, Shiratori K, Iwabe C, Watanabe S, Takeuchi T.
    J Gastroenterol; 1996 Apr 23; 31(2):249-53. PubMed ID: 8680546
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of the CCK-receptor antagonist loxiglumide and the M1-receptor antagonist telenzepine on the pancreatic protein response to intraduodenal tryptophan in dogs. First results.
    Teyssen S, Singer MV.
    Ann N Y Acad Sci; 1994 Mar 23; 713():368-71. PubMed ID: 8185190
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of gastrin releasing peptide on exocrine pancreatic secretion and plasma levels of CCK and PP in conscious dogs].
    Hosotani R, Inoue K, Okuno T, Miyata S, Tobe T.
    Nihon Shokakibyo Gakkai Zasshi; 1985 Apr 23; 82(4):664-72. PubMed ID: 4021169
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The cholecystokinin antagonist L-364,718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo.
    Anderson L, Dockray GJ.
    Eur J Pharmacol; 1988 Feb 09; 146(2-3):307-11. PubMed ID: 3371402
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Small intestinal and pancreatic microstructures are modified by an intraduodenal CCK-A receptor antagonist administration in neonatal calves.
    Biernat M, Zabielski R, Sysa P, Sosak-Swiderska B, Le Huërou-Luron I, Guilloteau P.
    Regul Pept; 1999 Dec 23; 85(2-3):77-85. PubMed ID: 10651060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.